Author: admin

OpenAI and Broadcom have announced a major collaboration to develop and deploy 10 gigawatts of custom AI accelerators, a move aimed at scaling AI infrastructure globally.

The partnership combines OpenAI’s expertise in AI model development with Broadcom’s networking and connectivity solutions, reflecting a significant investment in the future of artificial intelligence.

Under the agreement, OpenAI will design the AI accelerators and systems, which Broadcom will help develop and deploy.

The racks will use Broadcom’s Ethernet, PCIe, and optical connectivity solutions for both scale-up and scale-out applications, enabling efficient and cost-optimized performance for AI workloads.

Deployment of these systems is expected to begin in the second half of 2026 and continue through the end of 2029.

The collaboration allows OpenAI to integrate insights from its frontier AI models directly into hardware design, unlocking new levels of capability and intelligence.

“Partnering with Broadcom is a critical step in building the infrastructure needed to unlock AI’s potential and deliver real benefits for people and businesses,” said Sam Altman, co-founder and CEO of OpenAI. “Developing our own accelerators adds to the broader ecosystem of partners all building the capacity required to push the frontier of AI to provide benefits to all humanity,” he added.

Broadcom’s CEO Hock Tan highlighted the strategic significance of the partnership, calling it “a pivotal moment in the pursuit of artificial general intelligence.”

He noted that OpenAI has been at the forefront of the AI revolution and emphasized Broadcom’s role in co-developing and deploying next-generation accelerators and network systems.

Greg Brockman, co-founder and President of OpenAI, said the collaboration would “power breakthroughs in AI and bring the technology’s full potential closer to reality.”

By designing its own chips, OpenAI can embed lessons learned from creating advanced models directly into hardware, enhancing AI performance while maintaining energy efficiency.

For Broadcom, the partnership reinforces the importance of custom accelerators and standards-based Ethernet as the technology for scalable AI data centers.

Charlie Kawwas, President of Broadcom’s Semiconductor Solutions Group, added that the collaboration sets new industry benchmarks for open, scalable, and power-efficient AI clusters. He explained that the integration of custom accelerators with Broadcom’s networking solutions provides an optimized infrastructure for performance and cost.

OpenAI, which now serves over 800 million weekly active users, continues to expand adoption across global enterprises, small businesses, and developers.

This collaboration is expected to significantly enhance OpenAI’s capabilities while supporting its mission to ensure that artificial general intelligence benefits all of humanity.

The combined effort demonstrates the increasing demand for AI infrastructure and represents one of the largest initiatives in custom AI hardware development to date.

Also Read: Mahindra Lifespace Acquires Land in Pune for ₹3,500 Crore Housing Project

Foxconn, the Taiwanese electronics manufacturing giant, has announced a significant investment of ₹15,000 crore in Tamil Nadu, aiming to establish a robust manufacturing and research ecosystem in the state.

This initiative is set to create 14,000 high-value engineering jobs, marking a substantial contribution to Tamil Nadu’s industrial landscape.

The announcement was made following a meeting between Tamil Nadu Chief Minister M.K. Stalin and Foxconn’s India representative, Robert Wu, in Chennai on October 13, 2025.

The discussions underscored the deepening partnership between the state and Foxconn, reaffirming Tamil Nadu’s position as a preferred destination for high-tech manufacturing investments.

As part of this expansion, Foxconn will focus on value-added manufacturing, research and development (R&D) integration, and the implementation of artificial intelligence (AI)-led advanced technology operations. The investment will be distributed across multiple locations in Tamil Nadu, enhancing the state’s capabilities in electronics and advanced manufacturing sectors.

In a bid to streamline operations and facilitate faster project execution, the state government, through its investment promotion agency, Guidance Tamil Nadu, will establish a dedicated “Foxconn Desk.”

This initiative aims to provide seamless coordination and mission-mode engagement for Foxconn’s projects, ensuring efficient regulatory approvals and support.

Chief Minister Stalin expressed the government’s commitment to supporting Foxconn’s expansion, highlighting the state’s proactive industrial policies, world-class talent pool, and infrastructure readiness.

He assured full support through the state’s single-window investment facilitation mechanism and talent development partnerships.

Industries Minister T.R.B. Rajaa emphasized that this investment is the largest-ever commitment for Tamil Nadu in terms of engineering job creation, aligning with the state’s “Jobs for TN” initiative.

He termed it a major boost for Tamil Nadu’s electronics and advanced manufacturing sector, signaling the state’s growing appeal as a hub for electronics manufacturing and foreign investment in India.

Robert Wu, Foxconn’s India representative, conveyed the company’s confidence in Tamil Nadu’s governance model and industrial policies.

He noted that the state’s infrastructure readiness and ease of doing business make it a preferred destination for Foxconn’s next phase of growth in India, including strategic verticals such as battery technologies and AI-led manufacturing systems.

This development underscores Tamil Nadu’s transformation from a manufacturing destination to a strategic innovation and engineering hub for the global supply chain.

The state’s commitment to fostering a conducive environment for high-tech industries is expected to attract further investments, positioning Tamil Nadu as a key player in the global electronics manufacturing landscape.

Also Read: Enforcement Directorate Offers Flipkart Settlement in FEMA Violation

Bengaluru-based fintech firm Groww is set to launch its Initial Public Offering (IPO) in early November 2025, aiming to raise ₹7,000 crore (approximately $850 million) and achieve a valuation of up to $8 billion.

The offering includes a fresh issue of ₹1,060 crore and an offer for sale (OFS) of up to 574.2 million shares by existing investors and promoters.

Notable backers such as Microsoft CEO Satya Nadella, Peak XV Partners, Y Combinator, Ribbit Capital, and Tiger Global are among those reducing their stakes.

Company Overview

Founded in 2016, Groww has rapidly emerged as India’s largest retail brokerage platform by active clients, surpassing Zerodha. As of April 2025, the company boasts over 13 million active clients and holds a 26.27% market share among retail investors on the National Stock Exchange.

The firm offers a range of investment products, including stocks, mutual funds, ETFs, digital gold, and US equities, through its digital-only platform.

Financial Performance

In fiscal year 2025, Groww reported a significant financial performance, with a net profit of ₹1,819 crore, more than tripling from the previous year.

Revenue also saw a 31% increase, reaching ₹4,056 crore. These results underscore the company’s strong market position and growth trajectory in the wealth management sector.

Strategic Acquisition

Ahead of its IPO, Groww completed the acquisition of Bengaluru-based wealth management company Fisdom, following regulatory approval from the Securities and Exchange Board of India (SEBI).

This strategic move marks Groww’s official entry into the wealth management sector, expanding its footprint beyond its existing investment services.

The acquisition aligns with Groww’s broader objectives as it prepares for an IPO, signaling the company’s continued growth and diversification within the financial technology space.

Market Position and Outlook

The upcoming IPO is poised to be one of India’s largest fintech listings, positioning Groww as a key player in the country’s digital financial services industry. Market participants and investors will be closely watching the offering as it unfolds in the coming weeks.

Also Read: Coal India, IRCON Ink MoU to Boost Coal Rail Connectivity

Starlink, the satellite internet venture of Elon Musk’s SpaceX, is preparing to commence its satellite communication services in India, entering a market that already features competitors such as Eutelsat OneWeb and Jio Satellite.

The company has secured the necessary regulatory approvals, with the final step being the allocation of operational spectrum by the Department of Telecommunications (DoT) and the Telecom Regulatory Authority of India (TRAI).

A key focus of Starlink’s strategy in India is rural connectivity. Parnil Urdhwareshe, India Market Access Director at Starlink, highlighted that a significant portion of Starlink’s global user base resides in rural areas, where conventional broadband infrastructure is limited.

Serving these underserved regions is central to Starlink’s mission, as many users in these areas currently have restricted access to high-quality broadband services.

Starlink has been granted trial spectrum by the DoT to demonstrate compliance with security requirements. The department is finalizing pricing and other modalities for allocating spectrum to satellite communication firms.

The company is working to ensure it can deliver a compliant, secure, and reliable broadband experience for Indian users once the operational approvals are completed.

The Indian satellite communication market is becoming increasingly competitive. Eutelsat OneWeb, backed by Bharti Enterprises, has received authorizations from the Indian National Space Promotion and Authorization Center (IN-SPACe) to launch commercial satellite broadband services. Likewise, the Jio-SES joint venture has obtained the necessary regulatory clearances to operate in India, positioning multiple players to expand connectivity in both urban and rural regions.

Government regulations also set limits on subscriber numbers for each satellite communication system.

Starlink and other providers are subject to these restrictions to ensure fair pricing, service quality, and efficient spectrum usage.

The government has indicated that Starlink may have a maximum user base of 2 million in India due to spectrum capacity constraints.

Starlink’s move into India reflects both the growing demand for broadband services in rural areas and the need to optimize satellite capacity.

By targeting regions where conventional internet infrastructure is limited, the company aims to bridge connectivity gaps that have persisted for years, providing high-speed internet to schools, healthcare facilities, and households that previously relied on slower or inconsistent services.

Industry analysts note that while Starlink’s entry will expand broadband coverage, the competitive landscape and government-imposed subscriber limits will shape its growth trajectory.

The presence of established players like Eutelsat OneWeb and Jio Satellite means that differentiation through service quality, pricing, and customer support will be key to capturing market share.

As regulatory approvals near completion, Starlink is finalizing the infrastructure needed for a large-scale rollout. This includes deploying ground stations and ensuring that satellite capacity can support both urban and rural users efficiently.

The company’s emphasis on compliance with security norms and spectrum management demonstrates its approach to balancing rapid expansion with regulatory expectations.

With a combination of advanced satellite technology and a focus on underserved areas, Starlink aims to strengthen India’s digital ecosystem.

Its entry into the market is expected to enhance competition, increase broadband penetration, and provide new options for users who have historically faced limited internet access, particularly in rural and remote regions.

Also Read: Mukesh Ambani Retains Top Spot on Forbes India Rich List; Gautam Adani Second

BioInvent International AB has announced the initiation of a Phase 2a clinical trial evaluating its lead drug candidate BI-1206 in combination with Merck’s anti-PD-1 therapy KEYTRUDA® (pembrolizumab) for patients with advanced or metastatic non-small cell lung cancer (NSCLC) and uveal melanoma.

The Phase 2a study follows encouraging results from BioInvent’s Phase 1 trial, where BI-1206 was found to be safe, well-tolerated, and showed promising clinical activity in heavily pre-treated patients.

Out of 36 evaluable patients, one achieved a complete response, one had a long-lasting partial response, and 11 maintained stable disease, despite having progressed on prior anti-PD1/L1 therapies.

The subcutaneous formulation of BI-1206 was noted for slower systemic entry, prolonged time on target, and improved safety.

“We are very pleased to initiate Phase 2a studies, which marks a significant milestone in our mission to bring BI-1206 to patients,” said Martin Welschof, CEO of BioInvent.

“The early clinical signs of efficacy observed in Phase 1 provide a strong rationale for moving forward in the first-line setting for NSCLC and uveal melanoma. Since BI-1206 addresses a mechanism of resistance to anti-PD1, its potential extends to all indications where pembrolizumab is approved,” he added.

The trial, registered as NCT04219254, will enroll patients at sites across Georgia, Germany, Poland, Romania, Spain, Sweden, and the US, with initial data expected in the second half of 2026.

The study will be conducted in two parts: a signal-seeking phase including up to 30 NSCLC and 12 uveal melanoma patients receiving BI-1206 plus pembrolizumab every 21 days for up to two years, followed by a dose optimization phase. In this phase, patients will be randomized to higher or lower doses of BI-1206, with a third cohort receiving pembrolizumab alone.

NSCLC, the most common type of lung cancer, accounts for roughly 85 percent of all cases, but response rates to checkpoint inhibitors remain low, rarely exceeding 25 percent. Uveal melanoma, though rare, is the most frequent non-cutaneous melanoma in adults, with about 7,000 new cases globally each year.

BI-1206 is designed to counter resistance caused by FcγRIIB-mediated degradation of PD-1 antibodies, potentially enhancing responses to therapies like pembrolizumab.

BioInvent, a clinical-stage biotech company, focuses on discovering and developing first-in-class immune-modulatory antibodies for cancer immunotherapy.

Its proprietary F.I.R.S.T™ technology platform identifies new targets and antibodies, supporting both in-house development and licensing opportunities.

The Phase 2a trial represents a key step in assessing BI-1206’s potential to improve outcomes for patients with NSCLC and uveal melanoma while advancing BioInvent’s broader immuno-oncology pipeline.